STI571

What STI571 Means in Everyday Medical Language

STI571 is a drug used to treat certain types of cancer and rare conditions. It is better known by brand names such as Gleevec, Imatinib Mesylate, or Imkeldi. This medicine belongs to a group called tyrosine kinase inhibitors, which work by blocking specific proteins that help cancer cells grow and multiply. By stopping these proteins, STI571 can slow down or kill cancer cells. It is usually taken as a pill.

Why STI571 Can Matter in Cancer Care

STI571 has changed the treatment of some cancers by targeting the specific molecules that drive cancer growth. For example, in chronic myelogenous leukemia (CML), it blocks a protein called BCR-ABL, which is produced because of a genetic change known as the Philadelphia chromosome. By blocking this protein, STI571 helps many patients control their disease for a long time. It is also used to treat other cancers such as certain types of acute lymphoblastic leukemia (ALL), gastrointestinal stromal tumors (GIST), and a rare skin tumor called dermatofibrosarcoma protuberans (DFSP). It may be used when surgery is not possible or after surgery to reduce the chance of cancer returning.

What Patients Might See or Hear About STI571

You might see the name STI571 or its other names—Gleevec, Imatinib Mesylate, or Imkeldi—in your medical records, prescriptions, or drug information sheets. Because the drug has several names, it can be confusing. It’s important to talk with your healthcare team about how this drug fits into your specific treatment plan. Side effects can include nausea, diarrhea, muscle pain, rash, or more serious effects like fluid buildup or liver problems, so your care team will monitor you closely.

Where the Term STI571 Might Appear

STI571 may be mentioned in pathology reports, treatment plans, visit notes, clinical trial information, or drug guides. It might also appear under its generic name, imatinib mesylate, or other brand names like Gleevec or Imkeldi. Seeing these different names can be confusing, so comparing the wording and asking your care team for clarification is helpful.

What STI571 Does Not Automatically Mean

Seeing the name STI571 does not mean a specific diagnosis or guarantee a particular treatment outcome. This drug is used for many different cancers and conditions, so the presence of the name alone does not tell the whole story. It also does not mean the cancer is cured; often, STI571 helps control the disease over time. Treatment plans vary widely, so understanding how this drug applies to your care is important.

Common Sources of Confusion and Practical Questions

Because STI571 is known by several names, patients and caregivers may be confused when they see different terms in medical records or prescriptions. It’s helpful to ask your care team to explain what the drug is called in your case and how it fits into your treatment. You might ask, "What is this drug used for in my situation?", "What side effects should I watch for?", or "How will we know if the drug is working?"

How to Read the Term in Context

When you see STI571 mentioned, it’s best to consider it as part of your overall treatment plan rather than alone. Ask your healthcare team to explain what it means in your specific report, test result, or treatment discussion. This helps avoid misunderstandings and ensures you get clear information about your care.

Safety and Next Steps

This information is educational and cannot decide what is safe or appropriate for any individual patient. If STI571 appears in your medical records or treatment plan, the safest next step is to ask your healthcare team what it means for you personally. They can explain how this drug fits into your care, what to expect, and how to manage any side effects.